Literature DB >> 8316270

Treatment of patients with cancer of an unknown primary site.

J D Hainsworth1, F A Greco.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8316270     DOI： 10.1056/NEJM199307223290407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

1.  FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.

Authors:  Stefan A M Paul; Sandro J Stoeckli; Gustav K von Schulthess; Gerhard W Goerres
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-03       Impact factor: 2.503

2.  Second-line chemotherapy in patients with primary unknown cancer.

Authors:  Makiko Ono; Masashi Ando; Kan Yonemori; Harukaze Yamamoto; Taizo Hirata; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2011-05-11       Impact factor: 4.553

Review 3.  Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido.

Authors:  Julien Feghaly; George Astras
Journal:  BMJ Case Rep       Date:  2015-03-31

4.  Multiclass cancer diagnosis using tumor gene expression signatures.

Authors:  S Ramaswamy; P Tamayo; R Rifkin; S Mukherjee; C H Yeang; M Angelo; C Ladd; M Reich; E Latulippe; J P Mesirov; T Poggio; W Gerald; M Loda; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

5.  Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.

Authors:  Efnan Algin; Ahmet Ozet; Ozge Gumusay; Guldal Yilmaz; Suleyman Buyukberber; Ugur Coskun; Meltem Baykara; Bulent Cetin; Ramazan Yıldız; Mustafa Benekli
Journal:  Wien Klin Wochenschr       Date:  2015-09-15       Impact factor: 1.704

Review 6.  Unknown primary tumours.

Authors:  H F Hillen
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

7.  Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Authors:  Vikas Prasad; Valentina Ambrosini; Merten Hommann; Dieter Hoersch; Stefano Fanti; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

8.  Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules.

Authors:  Shoichiro Ohta; Yukiko Cho; Masaharu Shibata; Kimihiro Nagai; Tatsuo Iijima; Hitoaki Saito; Hirotaka Asakura; Hiroshi Kojima
Journal:  Exp Ther Med       Date:  2011-12-14       Impact factor: 2.447

9.  Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.

Authors:  J Ponce Lorenzo; A Segura Huerta; R Díaz Beveridge; A Giménez Ortiz; F Aparisi Aparisi; T Fleitas Kanonnikoff; P Richart Aznar; H de la Cueva Sapiña; J Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

Review 10.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.